Shrestha Rajeev, Shrestha Sunil, Sapkota Binaya, Khanal Saval, Kc Bhuvan
Lamjung District Community Hospital, Department of Pharmacy, Lamjung, Nepal
Monash University Malaysia, School of Pharmacy, Selangor, Malaysia
Turk J Pharm Sci. 2022 Apr 29;19(2):232-238. doi: 10.4274/tjps.galenos.2021.37974.
Coronavirus disease-2019 (COVID-19) is one of the greatest pandemics of modern times. More than one hundred eleven million global deaths have already been associated with COVID-19. The incidence of COVID-19 as well as morbidity and mortality due to COVID-19 have increased in low-income countries (LICs). COVID-19 has further weakened health systems in LICs, that are already distressed by inadequate funding, lack of human resources, and poor infrastructure and service delivery. Despite the resource crunch, hospital LICs have been instrumental in treating COVID-19 patients. Pharmacists working in hospitals play an indispensable role in providing pharmaceutical services for infection prevention and control. This study discusses the contribution of hospital pharmacists and the challenges faced by them for treating COVID-19 patients in LICs before the COVID-19 vaccine roll-out.
2019年冠状病毒病（COVID-19）是现代最严重的大流行病之一。全球已有超过1.11亿人死于COVID-19。低收入国家（LICs）的COVID-19发病率以及因COVID-19导致的发病率和死亡率都有所上升。COVID-19进一步削弱了低收入国家本就因资金不足、人力资源匮乏、基础设施和服务提供不佳而陷入困境的卫生系统。尽管资源紧张，但低收入国家的医院在治疗COVID-19患者方面发挥了重要作用。在医院工作的药剂师在提供感染预防和控制的药学服务方面发挥着不可或缺的作用。本研究讨论了在COVID-19疫苗推出之前，低收入国家医院药剂师在治疗COVID-19患者方面的贡献以及他们面临的挑战。
